|
⚲
|
| Starr Life Sciences Corp | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001365950 |
| Sale | 2008-01-30 ($2.1 M Offered, $1.8 M Sold) |
| Fund | |
| Phone | 8669782779 |
| Address | 333 Allegheny Avenue Oakmont, 15139 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Robert Crouch | |
| Patrick Stewart | |
| Christopher Brodman | |
| Donald Wagner | |
| Eric Starr |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Dawson Pat D
✚
|
0.0 | |
|
Dawson Teresa M
✚
|
0.0 | |
|
DayDream Ventures II, a Series of Assure Labs 2021, LLC
✚
|
0.0 | |
|
DB Fund I, a series of First Check Ventures, LP
✚
|
0.0 | |
|
dbX-CTA 19 Fund
✚
|
0.0 | |
|
dbX-Global Long/Short Equity 9 Fund
✚
|
0.0 | |
|
dbX-US Long/Short Equity 16 Fund
✚
|
0.0 | |
|
DCA ESG Solutions II LLC
✚
|
0.0 | |
|
DCA ESG Solutions I LLC
✚
|
0.0 | |
|
Davenport Investors LLC
✚
|
0.0 |